Get our introductory offer at only
*$0.99/month for first 3 months
$29.90/month for the next 9 months
VALEANT Pharmaceuticals International Inc cut its earnings guidance for next year and said it will pay down debt as the drugmaker tries to end questions about how it distributed many of its products.
Valeant said in a statement that its primary measure of profits, adjusted...